TrialTherapeutic advances in respiratory disease

Randomized, phase I studies to evaluate the safety, tolerability, and pharmacokinetics of an inhaled, TMEM16A potentiator, GDC-6988, in healthy subjects.

Paul Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.